These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16308978)

  • 1. [The role of Ki-67, mutant suppressor gene p53 and low mitotic levels in defining the prognosis for adult granulosa cell tumor of the ovary].
    Volkova AV; Chepik OF; Bakhidze EV; Ten VP
    Vopr Onkol; 2005; 51(4):455-9. PubMed ID: 16308978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of inhibin and p53 in granulosa cell tumors of the ovary.
    Gebhart JB; Roche PC; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2000 May; 77(2):232-6. PubMed ID: 10785470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer].
    Masliukova EA; Pozharisskiĭ KM; Karelin MI; Startsev VIu; Ten VP
    Vopr Onkol; 2006; 52(6):643-8. PubMed ID: 17338241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis.
    King LA; Okagaki T; Gallup DG; Twiggs LB; Messing MJ; Carson LF
    Gynecol Oncol; 1996 May; 61(2):227-32. PubMed ID: 8626138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary.
    Villella J; Herrmann FR; Kaul S; Lele S; Marchetti D; Natiella J; Odunsi K; Mhawech-Fauceglia P
    Int J Gynecol Pathol; 2007 Apr; 26(2):154-9. PubMed ID: 17413982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progression of leukoplakia is associated with changes in apoptotic and mitotic index as well as in p53 and Ki-67 expression].
    Kövesi G; Szende B
    Magy Onkol; 2002; 46(4):333-8. PubMed ID: 12563356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
    Gorban' NA; Ten VP; Pankratov VA
    Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in ovarian adult granulosa cell tumour.
    Miller K; McCluggage WG
    J Clin Pathol; 2008 Aug; 61(8):881-4. PubMed ID: 18663055
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of mitotic counts and Ki-67 immunoreactivity in adult-type granulosa cell tumour of the ovary.
    Leuverink EM; Brennan BA; Crook ML; Doherty DA; Hammond IG; Ruba S; Stewart CJ
    J Clin Pathol; 2008 Aug; 61(8):914-9. PubMed ID: 18430757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical markers as prognosticators in gynecologic oncology].
    Pozharisskiĭ KM; Vinokurov VL; Zharinov GM; Bolbarian NA; Kuznetsova ME; Gasparian NA; Samsonova EA
    Vopr Onkol; 2008; 54(4):463-70. PubMed ID: 18942401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of juvenile ovary granulose cell tumor].
    Huang JN; Liu YZ; Zhang XM
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):533-6. PubMed ID: 17983492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas.
    Høgdall EV; Christensen L; Høgdall CK; Frederiksen K; Gayther S; Blaakaer J; Jacobs IJ; Kjaer SK
    APMIS; 2008 May; 116(5):400-9. PubMed ID: 18452430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulosa cell tumor of the ovary. Immunohistochemical evidence of low proliferative activity and virtual absence of mutation of the p53 tumor-suppressor gene.
    Horny HP; Marx L; Kröber S; Lüttges J; Kaiserling E; Dietl J
    Gynecol Obstet Invest; 1999; 47(2):133-8. PubMed ID: 9949285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53, c-erbB-2, Ki-67, and CD34 in granulosa cell tumor of the ovary.
    Kusamura S; Derchain S; Alvarenga M; Gomes CP; Syrjänen KJ; Andrade LA
    Int J Gynecol Cancer; 2003; 13(4):450-7. PubMed ID: 12911721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
    Sakai K; Hongo K; Tanaka Y; Nakayama J
    Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.